Keyphrases
Deep Brain Stimulation
72%
Nucleus Accumbens
49%
Tardive Dyskinesia
41%
Subthalamic nucleus Deep Brain Stimulation (STN-DBS)
40%
Optogenetics
39%
Cocaine
37%
Striatal
35%
Dopamine Neurons
35%
Haloperidol
35%
Rodents
35%
Ventral Tegmental Area
34%
Synaptic Plasticity
34%
Ventral Pallidum
30%
Addiction
26%
GABA Neurons
25%
Subthalamic nucleus
23%
Neuromodulation
23%
Entopeduncular nucleus
23%
Antipsychotics
23%
Synaptic Transmission
22%
Vacuous Chewing Movements
22%
Home Cage
22%
Pallidal
21%
Medium Spiny Neurons
18%
Dorsolateral Striatum
16%
Synapse
16%
Rodent Models
15%
Reward-related Behavior
15%
Ventral Tegmental Area Dopamine Neurons
15%
Rat Model
15%
Dyskinetic
15%
Basal Ganglia
15%
Neural Circuits
14%
Striatum
13%
Addictive Drugs
13%
Motivation
12%
Food Motivation
12%
Neurostimulation
12%
Reward Seeking
12%
Potentiation
12%
Neuromodulation Therapy
11%
Motor Symptoms
11%
Negative Affect
10%
Optogenetic Stimulation
10%
Obesity
10%
Zif268
10%
Synaptic
10%
Adaptive Behavior
10%
Cocaine Exposure
10%
Chronic Pain
9%
Neuroscience
Behavior (Neuroscience)
100%
Deep Brain Stimulation
91%
Optogenetics
60%
Ventral Tegmental Area
49%
Nucleus Accumbens
45%
Tardive Dyskinesia
41%
Subthalamic Nucleus
41%
Synaptic Transmission
34%
Haloperidol
34%
Medium Spiny Neuron
33%
Ventral Pallidum
32%
Synaptic Plasticity
31%
Neuromodulation
26%
Gamma-Aminobutyric Acid
25%
In Vivo
24%
Striatum
22%
Parkinson's Disease
17%
Basal Ganglia
16%
Synapse
16%
Mental Disorder
15%
Antipsychotic
15%
Dopamine Receptor D1
12%
Neural Circuit
12%
Cholinergic
12%
Neurostimulation
11%
Endorphin
11%
Serotonin
10%
Anhedonia
9%
Obsessive-Compulsive Disorder
9%
Receptor
9%
Central Nervous System
9%
Dyskinesia
9%
Emotion
8%
Receptor Antagonist
8%
Antidepressant
8%
Habenula
8%
Genetic Mapping
8%
Impulsivity
8%
Oxycodone
7%
Scopolamine
7%
Hyperactivity
7%
2,5-Dimethoxy-4-iodoamphetamine
7%
Cholinergic Receptor
7%
Decision-Making
7%
Functional Connectivity
7%
Neurophysiology
7%
Cell Plasticity
7%
Serotonin Release
7%
Dopaminergic Neuron
7%
Electrotherapy
7%